Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thiner, Less Problematic Than Warfrain: Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)
Via Get News
Topics Death Economy
Exposures Death Product Safety Supply Chain
Tickers ABT CVKD
$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thinner, Less Problematic Than Warfrain: $CVKD
Via PRLog
Topics Death Economy
Exposures Death Product Safety Supply Chain
Addressing Powdering Issues in PE Film Processing: Constructive Solutions for Enhanced Production
Via AB Newswire
Topics Bonds Product Recall Supply Chain
Exposures Debt Markets Legal Product Safety
TechMediaBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Prepares for Potential Fibromyalgia Drug Approval, Reports Q1 Results
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire Kadima Neuropsychiatry Institute
Via Investor Brand Network
Exposures Product Safety
Tickers NRXP
How SeaStar Medical Joined Select Ranks Of Medical Device Innovators With Six FDA Breakthrough Device Designations
Via NewMediaWire
Exposures Product Safety
Tickers ICU
How SeaStar Medical Joined Select Ranks Of Medical Device Innovators With Six FDA Breakthrough Device Designations
Via TheNewswire.com
Exposures Product Safety
Tickers ICU
TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher?
Via The Motley Fool
Exposures Product Safety
Tickers TMDX
Thomas D'Aguanno Announces the Release of His Debut Novella StarStruck, Tapping into '90s Nostalgia with the Help of AI
Via Press Release Distribution Service
Topics Artificial Intelligence Intellectual Property Product Recall
Exposures Artificial Intelligence Intellectual Property Layoff
Moleculin Biotech Gets EMA Nod For Leukemia Trial: Retail Feels Bullish On ‘Low And Slow’ Setup
Via Stocktwits
Exposures Product Safety
Tickers MBRX
Full-Spectrum Organic CBD Oil For Pets, Pain & Anxiety Relief Formula Announced
Via Press Release Distribution Service
Topics Cannabis
Exposures Cannabis Product Safety
US Health Agencies Recommend Pausing Valneva's Chikungunya Vaccine For Older Adults After Adverse Events
Via Benzinga
Topics Death
Exposures Death Product Safety
Tickers VALN
Mental Health Awareness Month—Tennessee Enacts Psychotropic Testing Law
Via PRLog
Exposures Product Safety
SeaStar's QUELIMMUNE Therapy For Pediatric AKI Adopted By Hospitals In Multiple States, Adult Treatment In Pipeline
Via NewMediaWire
Exposures Product Safety
Tickers ICU
SeaStar's QUELIMMUNE Therapy For Pediatric AKI Adopted By Hospitals In Multiple States, Adult Treatment In Pipeline
Via TheNewswire.com
Exposures Product Safety
Tickers ICU
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Q1 2025 Results on May 15
Via Investor Brand Network
Exposures Product Safety
Tickers BMWYY NRXP
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Completes Dosing in Key Toxicity Studies for MS Drug Candidate
Via Investor Brand Network
Exposures Product Safety
Tickers QNTM
EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients
Via Benzinga
Exposures Product Safety
Tickers BMY LTRN
Avant Technologies and Ainnova Tech Begin Acquisition Talks Ahead of FDA Pre-Submission Meeting
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers AVAI
Listeria Outbreak Linked To California's Fresh & Ready Foods Prompts Recall Across 4 States — 10 Hospitalized As FDA, CDC Investigate Contamination
Via Benzinga
Exposures Product Safety
Tickers ACI
GILD Q1 Earnings Call: HIV Growth and Pipeline Momentum Offset Revenue Miss
Via StockStory
Exposures COVID-19 Product Safety
Tickers GILD
1 Healthcare Stock with Exciting Potential and 2 to Avoid
Via StockStory
Topics Stocks
Exposures COVID-19 Product Safety US Equities
Tickers AORT DXCM PNTG
Midnighties Launches Luxury Bamboo Sleepwear Featuring Built-In Bra-Like Support and Muffin-free Waistbands
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
Trump Appointed Martin Makary Targets Faster Drug Approvals With FDA Artificial Intelligence Overhaul
Via Benzinga
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political Product Safety
Tickers GOOG GOOGL MSFT
New FDA Leadership Could Raise The Bar For Drug Approvals
Via Benzinga
Exposures Product Safety
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic
Via Stocktwits
Exposures Product Safety
Tickers NSPR
Idaho Legal Delta-9 Disposables: Online Orders Of Hemp Products Announced
Via Press Release Distribution Service
Exposures Product Safety
Implications Of New FDA Leadership In The Biotechnology Industry
Via Talk Markets
Exposures Product Safety
Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish
Via Stocktwits
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers IWM OCGN VTI
Nutriband Inc. (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape
Via Investor Brand Network
Exposures Product Safety
Tickers BMWYY NTRB
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.